Domov › Metastatski rak › Florida › Miami
Klinične študije za Metastatski rak v Miami, FL
23 študij za Metastatski rak išče udeležence na lokacijah v Miami in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Vključevanje udeležencevFaza 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Vključevanje udeležencevFaza 3
- Research Site, Miami
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Vključevanje udeležencevFaza 2
- Sylvester Comprehensive Cancer Center, Miami
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Vključevanje udeležencevFaza 3
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Vključevanje udeležencevFaza 1/2
- Sylvester Comprehensive Cancer Center - Miami, Miami
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- University of Miami, Miami
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Miami Cancer Institute at Baptist Health, Inc., Miami
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
Vključevanje udeležencevFaza 1
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Vključevanje udeležencevFaza 3
- University Of Miami-SCCC-Miami, Miami
- University of Miami_SCCC - Kendall, Miami
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Vključevanje udeležencevFaza 3
- Research Site, Miami
- Research Site, Miami
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Vključevanje udeležencevFaza 1
- Sylvester Comprehensive Cancer Center, Miami
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Vključevanje udeležencevFaza 3
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Vključevanje udeležencevFaza 1/2
- University of Miami; Sylvester Cancer Center, Miami
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
Vključevanje udeležencevFaza 2/3
- Sylvester Comprehensive Cancer Center, Miami
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Vključevanje udeležencevFaza 2/3
- Sylvester Comprehensive Cancer Center, Miami
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Vključevanje udeležencevFaza 1
- Sylvester Comprehensive Cancer Center, Miami
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Vključevanje udeležencevFaza 1
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Vključevanje udeležencevFaza 3
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Miami
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Vključevanje udeležencevFaza 3
- Miami Cancer Institute, Miami
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- University of Miami, Miami
Študije za Metastatski rak v drugih mestih
- Houston, TX104 študij
- New York City, NY93 študij
- Nashville, TN70 študij
- Boston, MA63 študij
- Los Angeles, CA57 študij
- St. Louis, MO54 študij
- Arlington, VA53 študij
- Philadelphia, PA46 študij
- Chicago, IL45 študij
- San Antonio, TX44 študij
- Washington, DC43 študij
- Dallas, TX42 študij
Druge študije v Miami
- Rak dojke42 študij
- Rak (vse vrste)36 študij
- Nemalicelični pljučni rak31 študij
- Rak prostate27 študij
- Debelost27 študij
- Akutna mieločna levkemija24 študij
- Prekomerna telesna teža23 študij
- Rak jajčnikov23 študij
- Ulcerativni kolitis21 študij
- Množni mielom21 študij
- Alzheimerjeva bolezen20 študij
- Rak pljuč20 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.